The effect of Helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathy
2011

Helicobacter pylori Treatment and Central Serous Chorioretinopathy

Sample size: 50 publication Evidence: moderate

Author Information

Author(s): Rahbani-Nobar Mohammad Bagher, Javadzadeh Alireza, Ghojazadeh Leila, Rafeey Mandana, Ghorbanihaghjo Amir

Primary Institution: Tabriz University of Medical Sciences

Hypothesis

Does Helicobacter pylori treatment affect the remission of idiopathic central serous chorioretinopathy?

Conclusion

Anti-H. pylori treatment can lead to faster reabsorption of subretinal fluid in patients with idiopathic central serous chorioretinopathy.

Supporting Evidence

  • Subretinal fluid reabsorption time was significantly shorter in the treatment group.
  • All patients in the treatment group responded to the H. pylori eradication treatment.
  • No systemic adverse effects of medication were observed.

Takeaway

This study found that treating a stomach bug called H. pylori can help people with a specific eye problem get better faster.

Methodology

A randomized controlled trial with 50 patients divided into treatment and control groups, measuring visual acuity and subretinal fluid over 16 weeks.

Limitations

The study had a small sample size and short follow-up period.

Participant Demographics

Mean age was 32.54 years in the treatment group and 34.24 years in the control group, with a male to female ratio of approximately 4:1.

Statistical Information

P-Value

0.015

Statistical Significance

p=0.015

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication